Taro Pharmaceutical
TARO
#5055
Rank
A$2.43 B
Marketcap
A$64.69
Share price
0.00%
Change (1 day)
5.05%
Change (1 year)

Taro Pharmaceutical (TARO) - Total debt

Total debt on the balance sheet as of March 2023 : A$2.93 Million

According to Taro Pharmaceutical's latest financial reports the company's total debt is A$2.93 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Taro Pharmaceutical - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-03-31A$2.91 M-1.03%
2022-03-31A$2.94 M32.27%
2021-03-31A$2.22 M-9.85%
2020-03-31A$2.46 M
2019-03-31N/A
2015-03-31A$7.73 M-59.87%
2014-03-31A$19.27 M-29.84%
2013-03-31A$27.46 M
2011-12-31A$43.58 M-25.5%
2010-12-31A$58.49 M-67.91%
2009-12-31A$0.18 B-31.6%
2008-12-31A$0.26 B7.52%
2007-12-31A$0.24 B-17.95%
2006-12-31A$0.30 B-15.61%
2005-12-31A$0.35 B2.88%
2004-12-31A$0.34 B29%
2003-12-31A$0.26 B164.74%
2002-12-31A$0.10 B0.95%
2001-12-31A$0.10 B20.72%
2000-12-31A$83.59 M58.2%
1999-12-31A$52.84 M-1.65%
1998-12-31A$53.73 M17.47%
1997-12-31A$45.74 M53.32%
1996-12-31A$29.83 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
A$91.60 B 3,120,310.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$62.28 B 2,121,643.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.94 B 2,348,361.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.70 B 875,438.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$35.92 B 1,223,592.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$48.20 B 1,642,053.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland